SILINTAN 25/pills recall
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Why was SILINTAN 25/pills recalled?
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
All lots within expiry
- Product
- SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Recalling firm
- ANTHONY TRINH, 123Herbals LLC
- Quantity
- N/A
- Distribution
- USA nationwide
- Recall date
- March 11, 2026
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)